GGrantIndex
Sort

15,440 grants matching organoids

Analyzing the Hypersensitivity of MMR-deficient Colorectal Cancers to mTOR Inhibition and the Response of Cancer Stem Cells

$396,750
Winfried Edelmann · Albert Einstein College Of Medicine · R01 · FY2023 · CA

Analyzing the Hypersensitivity of MMR-deficient Colorectal Cancers to mTOR Inhibition and the Response of Cancer Stem Cells

$396,750
Winfried Edelmann · Albert Einstein College Of Medicine · R01 · FY2022 · CA

Stromal metabolism promotes therapeutic resistance in pancreatic cancer

$396,684
Costas Andreas Lyssiotis · University Of Michigan At Ann Arbor · R01 · FY2020 · CA

The Contribution of Microglial MEF2C to Brain Development

$396,661
Nicole Gabriele Coufal · University Of California, San Diego · R01 · FY2024 · NS

Metabolic reprogramming and FGF21 signaling in kidney health and polycystic kidney diseases

$396,609
Dao-Fu Dai · University Of Iowa · R01 · FY2022 · DK

Strategies for Receptor inhibition in immunotherapy

$396,586
Kenan Christopher Garcia · Stanford University · R01 · FY2021 · CA

Molecular Phenotyping and Image-Guidance for Surgical Treatment of High-Risk Prostate Cancer Using Ultrasmall Silica Nanoparticles

$396,582
Michelle S Bradbury · Sloan-Kettering Inst Can Research · R01 · FY2020 · CA

Metabolic regulation of exosome biogenesis as a determinant of cancer cell metastasis.

$396,573
Marc A Antonyak · Cornell University · R01 · FY2024 · CA

Cell type-specific influences on HHT pathogenesis

$396,384
Hua Su · University Of California, San Francisco · R01 · FY2015 · HL

SOX4-Mediated Transcription Program in Esophageal Adenocarcinoma

$396,308
Jianwen Que · University Of Miami School Of Medicine · P01 · FY2023 · CA

Core A: Pathobiology Core

$396,282
Massimo F Loda · Columbia University Health Sciences · P01 · FY2025 · CA

Progesterone Signaling and Blockade in Human Breast Tumorigenesis and Prevention

$396,152
Seema Ahsan Khan · Northwestern University At Chicago · R01 · FY2017 · CA

Progression, response, and resistance of RSPO fusion colorectal cancer

$396,129
Lukas Edward Dow · Weill Medical Coll Of Cornell Univ · R01 · FY2018 · CA

Ocular Gene Therapy

$396,078
Tiansen Li · National Eye Institute · ZIC · FY2024 · EY

Ceramide Signaling in the Regulation of Head & Neck Cancer Cell Death and Therapy

$396,078
Besim Ogretmen · Medical University Of South Carolina · R01 · FY2021 · DE

Ocular Gene Therapy

$396,078
Tiansen Li · National Eye Institute · ZIC · FY2025 · EY

Understanding Resistance to Next Generation Antiandrogens

$396,018
Charles L Sawyers · Sloan-Kettering Inst Can Research · R01 · FY2022 · CA

Lysyl oxidase induced esophageal remodeling in eosinophilic esophagitis

$396,000
Amanda Brooke Muir · Children'S Hosp Of Philadelphia · R01 · FY2023 · DK

Lysyl oxidase induced esophageal remodeling in eosinophilic esophagitis

$396,000
Amanda Brooke Muir · Children'S Hosp Of Philadelphia · R01 · FY2020 · DK

Lysyl oxidase induced esophageal remodeling in eosinophilic esophagitis

$396,000
Amanda Brooke Muir · Children'S Hosp Of Philadelphia · R01 · FY2021 · DK

Lysyl oxidase induced esophageal remodeling in eosinophilic esophagitis

$396,000
Amanda Brooke Muir · Children'S Hosp Of Philadelphia · R01 · FY2022 · DK

Thyroid Follicular Cell Signaling and Development in Humans

$395,999
Anthony N Hollenberg · Boston University Medical Campus · R01 · FY2024 · DK

Developmental Funds

$395,924
Cornelia M Ulrich · University Of Utah · P30 · FY2024 · CA

Role of Aryl Hydrocarbon Receptor in Microbiota-Colon Stem Cell Interactions

$395,905
Robert Stephen Chapkin · Texas A&M Agrilife Research · R01 · FY2016 · ES

Project 1: Determining and Exploiting Mechanisms of AR-Mediated Suppression of Cell Proliferation and Survival

$395,877
Peter S Nelson · Beth Israel Deaconess Medical Center · P01 · FY2023 · CA